vorherige Seite4 of 6nächste Seite
Financial Statements
Financial Statements
Bayer Group Consolidated Statements of Recognized Income and Expense
 3rd Quarter
2005
3rd Quarter
2006
First Nine Months 2005First Nine Months 2006
€ million     
Changes in fair values of hedging instruments and available-for-sale securities, recognized in stockholders’ equity40(39)32(51)
Actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits34(852)(1,100)335
Exchange differences on translation of operations outside the euro zone747686(428)
Deferred taxes on valuation adjustments, recognized directly in stockholders’ equity(17)353430(108)
Valuation adjustments recognized directly in stockholders’ equity64(491)48(252)
Income after taxes4963201,5531,372
Total income and expense recognized in the financial statements560(171)1,6011,120
   of which attributable to minority interest2(3)(6)(6)
   of which attributable to Bayer AG stockholders558(168)1,6071,126
top
top
top
top
top
top
top
top
top
Search
Search
Download Center
Services
Info
zoom - normal view 100% zoom +